PDF
Word
Form F252-127-000 Calcitonin Gene-Related Peptide (Cgrp) Receptor Antagonist for Treatment of Chronic Migraine - Washington
What Is Form F252-127-000?
This is a legal form that was released by the Washington State Department of Labor and Industries - a government authority operating within Washington. As of today, no separate filing guidelines for the form are provided by the issuing department.
FAQ
Q: What is F252-127-000?
A: F252-127-000 is a calcitonin gene-related peptide (CGRP) receptor antagonist used for the treatment of chronic migraine.
Q: What is a calcitonin gene-related peptide (CGRP) receptor antagonist?
A: A CGRP receptor antagonist is a type of medication that blocks the action of CGRP, a neurotransmitter involved in the development of migraines.
Q: What is chronic migraine?
A: Chronic migraine is a neurological condition characterized by experiencing migraine headaches on 15 or more days per month for at least 3 months.
Q: How does F252-127-000 work?
A: F252-127-000 works by blocking the receptors for CGRP, thereby preventing the transmission of pain signals and reducing the frequency and intensity of migraine attacks.
Q: Is F252-127-000 approved for the treatment of chronic migraine in Washington?
A: Yes, F252-127-000 is approved by the Washington state for the treatment of chronic migraine.
Form Details:
- Released on January 1, 2020;
- The latest edition provided by the Washington State Department of Labor and Industries;
- Easy to use and ready to print;
- Quick to customize;
- Compatible with most PDF-viewing applications;
- Fill out the form in our online filing application.
Download a fillable version of Form F252-127-000 by clicking the link below or browse more documents and templates provided by the Washington State Department of Labor and Industries.
